INTRODUCTION
Highly active anti-retroviral therapy (HAART) causes important interference in the natural history of HIV-1 infection. Haase (9) reported the impact of this treatment on suppressing viral replication that could be observed by VL determination. However, even with this vigorous action, the treatment did not completely eliminate the virus.
Pierson et al. (20) , considering the half-life of latently infected cells which are HIV-1 reservoirs, applied a mathematical model and concluded that more than 60 years of treatment would be required to eradicate this compartment. Regarding HIV surrogate markers, VL has been of great use, as the reduction in number of RNA copies per mL of plasma, often not detectable, has become an eloquent indicator of therapeutic action. The clinical evolution of concomitant patients shows increased survival, easier control of opportunistic infections, and a reduction in the number of deaths for patients under treatment (16) . According to Gougeon et al. Additionally, quantitative evaluation of these cells does not inform us which cytokines they are producing. Haase (9) , referring to naïve CD4 + T cell repopulation during treatment, mentioned that they slowly increase, but only many months after therapy introduction. According to the latter author, immunity regeneration is slow, variable and partial.
The main problem concerning HIV-1 infected individuals, when they are submitted to HAART, is the evaluation of immune function under this therapy interference. It is necessary to search for other markers to notice whether or not there is immunological recovery (4, 5) . Cytokine levels and the knowledge of their respective profiles can be evolution markers of immune response during ARV treatment. (14, 15) , in previous publications, demonstrated the importance of cytokines as evolution markers, mainly regarding HAART. Imami et al. (11) , in 1999, studied Th-1/Th-2 cytokine profiles in nine HIV patients before and during HAART by amplification and detection of specific cDNA, using real-time PCR. They suggested that the determination of cytokine profiles in HIV-1 in these two periods could complement information from VL and CD4 + T/mm 3 cell count (11) . This permitted to verify how the treatment affected the immune recovery in these patients.
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The objectives of the current study were: to evaluate the role of serum cytokines levels (TNF-α, INF-γ, IL-2, IL-4, and IL-10) and mRNA expression by real-time PCR, compare these two methods and examine Th-1, mature Th-0, and Th-2 cytokine profiles. Therefore, a cross-sectional study was employed to analyze three patient groups: "treatment virgins"; HAART with detectable VL; and HAART without detectable VL.
PATIENTS AND METHODS

Patients
Between and 62 years old (mean: 37 years).
Methods
• Groups
Group 1 (G 
Parameters considered
• Clinical parameters
All 73 infected individuals were submitted to clinical observation that included HIVassociated opportunistic diseases at the time of blood collection for cytokine detection.
•
Laboratorial parameters
The 73 persons (G 1 , G 2 , and G 3 ) were submitted at same time to: VL determination; • HIV-1 plasma viral load determination
Infected individuals were tested for HIV-1 plasma VL by the bDNA HIV-1 RNA QT system. The low limit for detection by this method was considered 50 copies/mL.
• CD4 + T and CD8 + T/mm 3 lymphocyte counts
The numbers of CD4 + and CD8 + T cells were measured from all HIV-infected patients in G 1 , G 2 , and G 3 using four-color flow cytometry and the commercially available Multitest IMK® kit (Becton Dickinson, USA) (13).
• Serum cytokine determination
We collected Serum cytokine concentrations were calculated from a standard curve (15, 17) . The detection limits of serum cytokines were 15.6 to 1,000 pg/mL for TNF-α and IFN-γ, 31.2 to 2,000 pg/mL for IL-2, 1.6 to 5,000 pg/mL for IL-4 and 3.2 to 10,000 pg/mL for IL-10.
• Cytokine dosage by amplification and specific cDNA detection using real- • Statistical analysis
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Mean ( X ), standard deviation (SD) and median (Md) were calculated for each group.
Comparison among groups G 1 , G 2 , G 3 and G 4 -regarding serum cytokines, amplification and detection of specific cDNA -was made by non-parametric KruskalWallis test (26) , with H and p statistics (chi-square distribution) and considering 
RESULTS
HAART
• ARV treatment scheme Comparison between groups showed no statistical difference (H = 1.281; p > 0.10;
VL behavior
VL mean for G 1 patients was 31,231 copies/mL (log 4.49), and for G 2 patients was 8,779 copies/mL (log 3.94). However, this type of treatment is not completely efficacious, since incapacity to perform HIV-1 clearance, or increase IL-2 production, suggests an inability to induce adaptive immune recovery. 
Comparison and correlation of cytokine levels in serum (ELISA) and by amplification and specific cDNA detection using real-time PCR (RT-PCR)
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INF-γ H = 47.678 H = 49.614 Both methods were studied by linear correlation between two measurements followed by linear regression, which revealed an association among almost all cytokines (except for IL-2). Consequently, ELISA and RT-PCR methods demonstrated analogous behaviors. Tables 2 and 3 
CONCLUSIONS
The results of the current study allow us to state that there is an association between the two methods employed to measure cytokine levels, except for IL-2 values. The different behaviors between ELISA and RT-PCR regarding this cytokine cannot be explained based on result analysis. Therefore, other studies are necessary to investigate this unexpected behavior.
Judging by the persistently low level of IL-2, even in individuals under HAART for several years and with undetectable viral load, these patients do not show any evidence of immune recuperation.
